Correction to: Phase 1 dose-escalation study of a novel oral PI3K/mTOR dual inhibitor, LY3023414, in patients with cancer

Autor:	Shunsuke Kondo, Koichi Inoue, Hiroya Asou, Masaomi Tajimi, Toshihiko Doi, Tomohiko Funai, Vinay Kumar Ranka, Volker Wacheck
Rok vydání:	2020
Předmět:	Pharmacology Oncology medicine.medical_specialty business.industry Pharmacology toxicology Dual inhibitor Cancer Internet portal medicine.disease Internal medicine medicine Dose escalation Pharmacology (medical) In patient business PI3K/AKT/mTOR pathway
Zdroj:	Investigational New Drugs. 38:1846-1846
ISSN:	1573-0646 0167-6997
DOI:	10.1007/s10637-020-00981-8
Popis:	The article Phase 1 dose-escalation study of a novel oral PI3K/mTOR dual inhibitor, LY3023414, in patients with cancer, written by Shunsuke Kondo, Masaomi Tajimi, Tomohiko Funai, Koichi Inoue, Hiroya Asou, Vinay Kumar Ranka, Volker Wacheck, Toshihiko Doi, was originally published electronically on the publisher's internet portal on 23 June 2020 without open access.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::abdb0063c607d8a57a7cf0b6dcc9bc20 https://doi.org/10.1007/s10637-020-00981-8 Zobrazit plný text záznamu Full text from SpringerLink